Enhanced production of taxadiene in Saccharomyces cerevisiae

BACKGROUND: Cost-effective production of the highly effective anti-cancer drug, paclitaxel (Taxol(®)), remains limited despite growing global demands. Low yields of the critical taxadiene precursor remains a key bottleneck in microbial production. In this study, the key challenge of poor taxadiene s...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowrouzi, Behnaz, Li, Rachel A., Walls, Laura E., d’Espaux, Leo, Malcı, Koray, Liang, Lungang, Jonguitud-Borrego, Nestor, Lerma-Escalera, Albert I., Morones-Ramirez, Jose R., Keasling, Jay D., Rios-Solis, Leonardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607689/
https://www.ncbi.nlm.nih.gov/pubmed/33138820
http://dx.doi.org/10.1186/s12934-020-01458-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607689/
https://www.ncbi.nlm.nih.gov/pubmed/33138820
http://dx.doi.org/10.1186/s12934-020-01458-2

Ejemplares similares